GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,084,000 | +134.6% | 5,000 | +25.0% | 0.00% | – |
Q4 2020 | $462,000 | +18.5% | 4,000 | 0.0% | 0.00% | – |
Q3 2020 | $390,000 | -20.4% | 4,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $490,000 | +12.6% | 4,000 | +6.2% | 0.00% | – |
Q3 2019 | $435,000 | -69.1% | 3,765 | -53.9% | 0.00% | -100.0% |
Q2 2019 | $1,408,000 | -4.9% | 8,165 | -7.0% | 0.00% | 0.0% |
Q1 2019 | $1,480,000 | +89.0% | 8,780 | +8.5% | 0.00% | 0.0% |
Q4 2018 | $783,000 | -55.1% | 8,090 | -19.8% | 0.00% | -50.0% |
Q3 2018 | $1,743,000 | +23.8% | 10,090 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $1,408,000 | +23.8% | 10,090 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,137,000 | -14.6% | 10,090 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,332,000 | +30.1% | 10,090 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,024,000 | +1.7% | 10,090 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,007,000 | -18.5% | 10,090 | -1.1% | 0.00% | 0.0% |
Q1 2017 | $1,235,000 | -12.9% | 10,200 | -19.6% | 0.00% | 0.0% |
Q4 2016 | $1,418,000 | – | 12,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |